UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005844
Receipt number R000006781
Scientific Title Clinical multi-center study of OTC periodontal ointment-containing applicator with brush (MC2) for reducing risk of relapse of chronic periodontitis during supportive periodontal therapy
Date of disclosure of the study information 2011/06/24
Last modified on 2016/12/27 12:05:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical multi-center study of OTC periodontal ointment-containing applicator with brush (MC2) for reducing risk of relapse of chronic periodontitis during supportive periodontal therapy

Acronym

Clinical multi-center study of OTC periodontal ointment-containing applicator with brush (MC2)

Scientific Title

Clinical multi-center study of OTC periodontal ointment-containing applicator with brush (MC2) for reducing risk of relapse of chronic periodontitis during supportive periodontal therapy

Scientific Title:Acronym

Clinical multi-center study of OTC periodontal ointment-containing applicator with brush (MC2)

Region

Japan


Condition

Condition

chronic periodontitis

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

OTC periodontal ointment-containing applicator with brush (MC2) is a medication enclosing of three active compounds of bactericidal agent, anti-inflammatory agent and tissue regeneration and wound healing agent. This study aims to examine clinical and microbacteriological effectiveness of MC2 for a maintaining and improvement of chronic periodontitis during SPT in a multi-center study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Probing pocket depth(PPD)
Bleeding score(BOP score)
Gingival index(GI)

Key secondary outcomes

Number of bacteria in subgingival plaque
Clinical attachment level(CAL)
Plaque control record(PCR)
Probing attachment level in horizontal and vertical direction(PAL-H, PAL-V)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine Device,equipment

Interventions/Control_1

test
After it brushes with a prescribed fluoridated dentifrice and a toothbrush, the proper quantity (rice grain outline 0.03g teeth) of the test preparations spread two times of the day (morning and evening) on the marginal gingiva of corresponding molar for 12 weeks.

Interventions/Control_2

placebo
After it brushes with a prescribed fluoridated dentifrice and a toothbrush, the proper quantity (rice grain outline 0.03g teeth) of the placebo preparations spread two times of the day (morning and evening) on the marginal gingiva of corresponding molar for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Person who has ended initial preparation (Surgical treatment is included) of chronic periodontitis, stabilizes the condition, and passes one year or more from SPT beginning in the university hospitals of the clinical trial.
(2) 20-year-old or more person
(3) Person who remains 15 present numbers or more of teeth
(4) Person whom explanation is received by using explanation book, and patient himself agrees to by document

Key exclusion criteria

(1) Person while being getting pregnant or suckling
(2) Person who has allergy symptom for either of three active compounds (cetylpyridinium chloride, dipotassium glycyrrhizate and allantoin)
(3) Person who has systemic disease (diabetic and autoimmune disease) that influences periodontal tissue
(4) Person who takes anticoagulant or has tendency to hemorrhages
(5) Person of while undergoing cancer therapy
(6) Person who received organ transplant in the past
(7) Person who took medicines such as antibiotics and antiphlogistic within three months in the past
(8) Person who did local drug delivery system of antibiotic in mouth within three months in the past
(9) Person who judged that charge dentist is not suitable

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shogo Takashiba

Organization

Okayama University

Division name

Department of Pathophysiology - Periodontal Science, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama, Japan

TEL

086-235-6675

Email

stakashi@cc.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shogo Takashiba

Organization

Okayama University

Division name

Department of Pathophysiology - Periodontal Science, Graduate School of Medicine, Dentistry and Pha

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama, Japan

TEL

086-235-6675

Homepage URL


Email

stakashi@cc.okayama-u.ac.jp


Sponsor or person

Institute

Okayama University

Institute

Department

Personal name



Funding Source

Organization

Okayama University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

University of Tokushima Graduate School
Tokyo Medical and Dental University
Osaka University Graduate School of Dentistry
Tsurumi University School of Dental Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岡山大学病院(岡山県)、徳島大学病院(徳島県)、東京医科歯科大学歯学部附属病院(東京都)、大阪大学歯学部附属病院(大阪府)、鶴見大学歯学部附属病院(神奈川県)
Okayama University Hospital(Okayama), Tokushima University Hospital(Tokushima), Tokyo Medical and Dental University Hospital Faculty of Dentistry(Tokyo), Okasa University Dental Hospital(Osaka), Tsurumi University Dental Hospital(Kanagawa)


Other administrative information

Date of disclosure of the study information

2011 Year 06 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2011 Year 08 Month 01 Day

Last follow-up date

2011 Year 12 Month 01 Day

Date of closure to data entry

2012 Year 03 Month 01 Day

Date trial data considered complete

2012 Year 03 Month 01 Day

Date analysis concluded

2012 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 06 Month 24 Day

Last modified on

2016 Year 12 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006781


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name